Literature DB >> 8633812

Efficacy dose determination study of tilmicosin phosphate in feed for control of pneumonia caused by Actinobacillus pleuropneumoniae in swine.

G M Moore1, D H Mowrey, L V Tonkinson, K F Lechtenberg, J H Schneider.   

Abstract

OBJECTIVE: To determine the effective dosage of tilmicosin phosphate when fed to pigs for the control of pneumonia attributable to Actinobacillus pleuropneumoniae.
DESIGN: Randomized complete block design, with initial weight as the blocking factor. ANIMALS: Seeder pigs were used to infect clinically normal male and female pigs weighing between 13.6 and 36.3 kg at each of 4 trials. PROCEDURE: Five doses of tilmicosin phosphate (0, 100, 200, 300, and 400 micrograms/g) were fed to pigs for 21 days. Pigs received experimental feeds 7 days before the seeder pigs were placed into pens. Feeding continued for an additional 14 days, with seeder pigs removed 3 to 8 days after placement. All pigs were euthanatized and necropsied, with lung bacterial flora and percentages of pneumonic involvement determined.
RESULTS: Improvement in clinical impression score, daily rectal temperature, and weight gain were seen for all doses of tilmicosin, compared with controls. For the same variables, tilmicosin administered at 200 to 400 micrograms/g resulted in improvements over the 100 micrograms/g dose.
CONCLUSIONS: Data indicate that tilmicosin phosphate fed to pigs at 200 to 400 micrograms/g is effective in controlling and preventing A pleuropneumoniae-induced pneumonia, when administered in feed for 21 days.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8633812

Source DB:  PubMed          Journal:  Am J Vet Res        ISSN: 0002-9645            Impact factor:   1.156


  4 in total

Review 1.  Immuno-modulation and anti-inflammatory benefits of antibiotics: the example of tilmicosin.

Authors:  André G Buret
Journal:  Can J Vet Res       Date:  2010-01       Impact factor: 1.310

2.  Assessment of the efficacy of tilmicosin phosphate to eliminate Actinobacillus pleuropneumoniae from carrier pigs.

Authors:  N Fittipaldi; C Klopfenstein; M Gottschalk; A Broes; M A Paradis; C P Dick
Journal:  Can J Vet Res       Date:  2005-04       Impact factor: 1.310

3.  Efficacy of tilmicosin in the control of experimentally induced Actinobacillus pleuropneumoniae infection in swine.

Authors:  Marie-Anne Paradis; Gordon H Vessie; John K Merrill; C Paul Dick; Camille Moore; George Charbonneau; M Gottschalk; Janet I MacInnes; Robert Higgins; K R Mittal; C Girard; Jeffery J Aramini; Jeffrey B Wilson
Journal:  Can J Vet Res       Date:  2004-01       Impact factor: 1.310

4.  Comparison of four lung scoring systems for the assessment of the pathological outcomes derived from Actinobacillus pleuropneumoniae experimental infections.

Authors:  Marina Sibila; Virginia Aragón; Lorenzo Fraile; Joaquim Segalés
Journal:  BMC Vet Res       Date:  2014-07-19       Impact factor: 2.741

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.